Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lamotrigine--a novel approach

B S Meldrum1

  • 1Department of Neurology, King's College Hospital, London, UK.

Seizure
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Lamotrigine is an effective anticonvulsant that works by prolonging sodium channel inactivation, reducing pathological glutamate release, and offering cerebroprotection. It has a favorable pharmacokinetic profile, with significant interactions noted with sodium valproate.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurotransmission in epilepsy.

Epilepsia·2012
Same author

Glutamate receptors and schizophrenia.

Journal of psychopharmacology (Oxford, England)·2011
Same author

Brain regional amino acid levels in seizure susceptible rats: Changes related to sound-induced seizures.

Neurochemistry international·2010
Same author

Actions of whole and fractionated indian cobra (naja naja) venom on skeletal muscle.

British journal of pharmacology and chemotherapy·2008
Same author

Why and when are seizures bad for the brain?

Trends in pharmacological sciences·2001
Same author

Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid.

European journal of pharmacology·2001

Area of Science:

  • Neuroscience
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Lamotrigine is an anticonvulsant structurally related to pyrimidine.
  • It demonstrates potent anticonvulsant activity with prolonged action and minimal acute neurotoxicity in rodent models.

Purpose of the Study:

  • To investigate the neuroprotective and pharmacokinetic properties of lamotrigine.
  • To elucidate the mechanisms underlying its anticonvulsant and cerebroprotective effects.

Main Methods:

  • Maximal electroshock test in rodents.
  • Assessment of sodium channel inactivation and glutamate release.
  • Pharmacokinetic profiling and drug interaction studies.

Main Results:

Related Experiment Videos

  • Lamotrigine suppresses sustained neuronal firing by prolonging sodium channel inactivation.
  • It inhibits pathological glutamate and aspartate release, conferring cerebroprotection in stroke models.
  • Lamotrigine exhibits linear pharmacokinetics, is rapidly absorbed, and does not induce liver enzymes.
  • Concomitant administration with sodium valproate significantly doubles lamotrigine's half-life.

    • Conclusions:

    • Lamotrigine's mechanism involves sodium channel modulation and glutamate release suppression.
    • Its favorable pharmacokinetics and cerebroprotective effects make it a promising therapeutic agent.
    • Clinically significant drug interactions, particularly with valproate, require careful consideration.